{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:47:59Z","timestamp":1791236879746,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shire"},{"DOI":"10.13039\/100007816","name":"Alcon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007816","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shire"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.exer.2019.107763","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T02:01:17Z","timestamp":1565748077000},"page":"107763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice"],"prefix":"10.1016","volume":"188","author":[{"given":"J. Cameron","family":"Millar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneli","family":"Savinainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene","family":"Josiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iok-Hou","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.107763_bib1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.peptides.2004.09.023","article-title":"Natriuretic peptide receptor-C signaling and regulation","volume":"26","author":"Anand-Srivastava","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.exer.2019.107763_bib2","first-page":"1647","article-title":"Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits","volume":"31","author":"Becker","year":"1990","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/14728214.7.1.141","article-title":"Advances in glaucoma therapeutics","volume":"7","author":"Clark","year":"2002","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.exer.2019.107763_bib4","first-page":"2629","article-title":"Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles","volume":"38","author":"Ding","year":"1997","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib3a","doi-asserted-by":"crossref","first-page":"C1378","DOI":"10.1152\/ajpcell.00363.2007","article-title":"NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel","volume":"294","author":"Dismuke","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2019.107763_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/edrv-15-2-135","article-title":"The family of guanylyl cyclase receptors and their ligands","volume":"15","author":"Drewett","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.exer.2019.107763_bib2a","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1167\/iovs.08-2750","article-title":"Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork","volume":"50","author":"Ellis","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib5a","first-page":"2625","article-title":"Carbachol and nitric oxide inhibition of Na,K-ATPase activity in bovine ciliary processes","volume":"42","author":"Ellis","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib6a","doi-asserted-by":"crossref","first-page":"C1685","DOI":"10.1152\/ajpcell.2000.279.6.C1685","article-title":"Carbachol inhibits Na(+)-K(+)-ATPase activity in choroid plexus via stimulation of the NO\/cGMP pathway","volume":"279","author":"Ellis","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2019.107763_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0014-4835(05)80023-5","article-title":"Messenger RNAs encoding the natriuretic peptides and their receptors are expressed in the eye","volume":"61","author":"Fernandez-Durango","year":"1995","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107763_bib7","doi-asserted-by":"crossref","first-page":"C655","DOI":"10.1152\/ajpcell.00552.2003","article-title":"Inhibition of NHE-1 Na+\/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium","volume":"287","author":"Fidzinski","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2019.107763_bib4a","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.exer.2010.12.003","article-title":"Effect of nitric oxide compounds on monkey ciliary muscle in vitro","volume":"93","author":"Gabelt","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107763_bib7a","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1167\/iovs.15-18958","article-title":"The Soluble Guanylate Cyclase stimulator IWP-953 increases conventional outflow facility in mouse eyes","volume":"57","author":"Ge","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107763_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40265-018-0877-7","article-title":"Netarsudil ophthalmic solution 0.02%: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2019.107763_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2147\/OPTH.S44708","article-title":"Managing adverse effects of glaucoma medications","volume":"8","author":"Inoue","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107763_bib11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107763_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/jop.2017.0138","article-title":"The effects of netarsudil ophthalmic solution on aqueous humor dynamics in a randomized study in humans","volume":"34","author":"Kazemi","year":"2018","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2019.107763_bib1a","first-page":"2769","article-title":"Effect of 8-Br cGMP on aqueous humor dynamics in monkeys","volume":"35","author":"Kee","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1672777","article-title":"Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)","volume":"252","author":"Koller","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.exer.2019.107763_bib14","first-page":"2385","article-title":"Atrial natriuretic peptides. Effects on intraocular pressure, cGMP, and aqueous flow","volume":"30","author":"Korenfeld","year":"1989","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib9a","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1076\/ceyr.26.2.119.14511","article-title":"Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits","volume":"26","author":"Kotikoski","year":"2003","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107763_bib15","first-page":"477","article-title":"Antiglaucomatous treatments and ocular surface","volume":"95","author":"Lajmi","year":"2017","journal-title":"La Tunis. Med."},{"key":"10.1016\/j.exer.2019.107763_bib16","first-page":"S279","article-title":"Current therapeutic options and treatments in development for the management of primary open-angle glaucoma","volume":"23","author":"Liebmann","year":"2017","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.exer.2019.107763_bib17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archopht.123.10.1351","article-title":"Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma","volume":"123","author":"Medeiros","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107763_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1167\/iovs.10-6069","article-title":"Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion","volume":"52","author":"Millar","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib19","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1167\/iovs.15-16720","article-title":"Strain and age effects on aqueous humor dynamics in the mouse","volume":"56","author":"Millar","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jop.1997.13.1","article-title":"Atriopeptin lowers aqueous humor formation and intraocular pressure and elevates ciliary cyclic GMP but lacks uveal vascular effects in the bovine perfused eye","volume":"13","author":"Millar","year":"1997","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2019.107763_bib21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3109\/02713688709025228","article-title":"Atrial natriuretic peptide (ANP), guanylate cyclase, and intraocular pressure in the rabbit eye","volume":"6","author":"Mittag","year":"1987","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107763_bib22","first-page":"1357","article-title":"Atriopeptin-activated guanylate cyclase in the anterior segment. Identification, localization, and effects of atriopeptins on IOP","volume":"28","author":"Nathanson","year":"1987","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0022-3565(25)11469-9","article-title":"Nitrovasodilators as a new class of ocular hypotensive agents","volume":"260","author":"Nathanson","year":"1992","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exer.2019.107763_bib24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.2042-7158.1988.tb05177.x","article-title":"Selective beta 2-adrenoceptor antagonists: derivatives of ICI 118,551 and a binary aryloxypropanolamine","volume":"40","author":"Nathanson","year":"1988","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.exer.2019.107763_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/02713689409042398","article-title":"Preliminary characterization of a transformed cell strain derived from human trabecular meshwork","volume":"13","author":"Pang","year":"1994","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107763_bib26","first-page":"1724","article-title":"Presence of functional type B natriuretic peptide receptor in human ocular cells","volume":"37","author":"Pang","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib27","doi-asserted-by":"crossref","first-page":"14531","DOI":"10.1016\/S0021-9258(18)42069-8","article-title":"Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization","volume":"267","author":"Potter","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exer.2019.107763_bib28","doi-asserted-by":"crossref","first-page":"P112","DOI":"10.1016\/j.ophtha.2015.10.055","article-title":"Primary open-angle glaucoma suspect Preferred Practice Pattern guidelines","volume":"123","author":"Prum","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107763_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107763_bib30","first-page":"28","article-title":"The phase 3 pipeline - glaucoma drugs in the works, glaucoma today","author":"Rhee","year":"2015","journal-title":"Bryn. Mawr Commun."},{"key":"10.1016\/j.exer.2019.107763_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-4835(91)90081-O","article-title":"Effects of atrial natriuretic factor (ANF) on intraocular pressure and aqueous humor flow in the cynomolgus monkey","volume":"53","author":"Samuelsson-Almen","year":"1991","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107763_bib32","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/sj.bjp.0702681","article-title":"Atriopeptin, sodium azide and cyclic GMP reduce secretion of aqueous humour and inhibit intracellular calcium release in bovine cultured ciliary epithelium","volume":"127","author":"Shahidullah","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2019.107763_bib8a","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.bjp.0706156","article-title":"Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye","volume":"145","author":"Shahidullah","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2019.107763_bib33","first-page":"2765","article-title":"Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits","volume":"35","author":"Stein","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/hrt.72.6.504","article-title":"Effect of ACE inhibitors on the atrial natriuretic peptides in heart failure","volume":"72","author":"Struthers","year":"1994","journal-title":"Br. Heart J."},{"key":"10.1016\/j.exer.2019.107763_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-2999(86)90292-X","article-title":"Synthetic atrial natriuretic factor lowers rabbit intraocular pressure","volume":"130","author":"Sugrue","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2019.107763_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/exer.1997.0403","article-title":"Ocular hypotension induced by intravitreally injected C-type natriuretic peptide","volume":"66","author":"Takashima","year":"1998","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107763_bib37","first-page":"2671","article-title":"Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit","volume":"37","author":"Takashima","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib38","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107763_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00230872","article-title":"Peptides from the N-terminus of the atrial natriuretic factor prohormone enhance guanylate cyclase activity and increase cyclic GMP levels in a wide variety of tissues","volume":"109","author":"Vesely","year":"1992","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.exer.2019.107763_bib40","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1167\/iovs.05-0781","article-title":"Noninvasive measurement of rodent intraocular pressure with a rebound tonometer","volume":"46","author":"Wang","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107763_bib41","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.exer.2019.107763_bib43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/108076803322472999","article-title":"CNP-induced changes in pHi, cGMP\/cAMP and mRNA expression of natriuretic peptide receptors in human trabecular meshwork cells","volume":"19","author":"Zhong","year":"2003","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519303835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519303835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:00:44Z","timestamp":1757998844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519303835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":51,"alternative-id":["S0014483519303835"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.107763","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.107763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107763"}}